Comparison of Cefazolin and Ceftriaxone as Antimicrobial Prophylaxis in Pancreatoduodenectomy with Preoperative Drainage: Incidence of Surgical Site Infection and Susceptibility of Bacteria in Bile.


Journal

World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052

Informations de publication

Date de publication:
Dec 2023
Historique:
accepted: 07 08 2023
medline: 5 12 2023
pubmed: 25 9 2023
entrez: 24 9 2023
Statut: ppublish

Résumé

The optimal perioperative antimicrobial agent for preventing surgical site infection (SSI) in pancreatoduodenectomy (PD) with preoperative biliary drainage (PBD) remains unclear. We retrospectively reviewed 288 patients who underwent PD after PBD between 2010 and 2020 at our institution. Patients were classified into two groups according to the perioperative antimicrobial agent used (cefazoline [CEZ] group [n = 108] and ceftriaxone [CTRX] group [n = 180]). The incidence of SSI, type of bacteria in intraoperative bile culture (IBC), and antimicrobial susceptibility to prophylactic antimicrobial agents were analyzed. The incidence of incisional SSI was significantly lower in the CTRX group than in the CEZ group (18% vs. 31%, P = 0.021), whereas the incidence of organ/space SSI in the two groups did not differ to a statistically significant extent (35% vs. 44%, P = 0.133). Gram-negative rod (GNR) bacteria in the IBC showed better antimicrobial susceptibility in the CTRX group than in the CEZ group. In multivariate analysis, antimicrobial resistance due to GNR was a significant risk factor for incisional SSI (odds ratio, 3.50; P < 0.001). CTRX had better antimicrobial coverage than CEZ for GNR cultured from intraoperative bile samples. In addition, CTRX provides better antimicrobial prophylaxis than CEZ against superficial SSI in patients with PD after PBD. This study was not a clinical trial and had no registration numbers.

Sections du résumé

BACKGROUND BACKGROUND
The optimal perioperative antimicrobial agent for preventing surgical site infection (SSI) in pancreatoduodenectomy (PD) with preoperative biliary drainage (PBD) remains unclear.
METHODS METHODS
We retrospectively reviewed 288 patients who underwent PD after PBD between 2010 and 2020 at our institution. Patients were classified into two groups according to the perioperative antimicrobial agent used (cefazoline [CEZ] group [n = 108] and ceftriaxone [CTRX] group [n = 180]). The incidence of SSI, type of bacteria in intraoperative bile culture (IBC), and antimicrobial susceptibility to prophylactic antimicrobial agents were analyzed.
RESULTS RESULTS
The incidence of incisional SSI was significantly lower in the CTRX group than in the CEZ group (18% vs. 31%, P = 0.021), whereas the incidence of organ/space SSI in the two groups did not differ to a statistically significant extent (35% vs. 44%, P = 0.133). Gram-negative rod (GNR) bacteria in the IBC showed better antimicrobial susceptibility in the CTRX group than in the CEZ group. In multivariate analysis, antimicrobial resistance due to GNR was a significant risk factor for incisional SSI (odds ratio, 3.50; P < 0.001).
CONCLUSIONS CONCLUSIONS
CTRX had better antimicrobial coverage than CEZ for GNR cultured from intraoperative bile samples. In addition, CTRX provides better antimicrobial prophylaxis than CEZ against superficial SSI in patients with PD after PBD.
TRIAL REGISTRATION NUMBER BACKGROUND
This study was not a clinical trial and had no registration numbers.

Identifiants

pubmed: 37743380
doi: 10.1007/s00268-023-07174-3
pii: 10.1007/s00268-023-07174-3
doi:

Substances chimiques

Cefazolin IHS69L0Y4T
Ceftriaxone 75J73V1629
Anti-Bacterial Agents 0
Anti-Infective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3298-3307

Informations de copyright

© 2023. The Author(s) under exclusive licence to Société Internationale de Chirurgie.

Références

Kimura W, Miyata H, Gotoh M et al (2014) A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy. Ann Surg 259:773–780
doi: 10.1097/SLA.0000000000000263 pubmed: 24253151
Elliott IA, Chan C, Russell TA et al (2017) Distinction of risk factors for superficial vs organ-space surgical site infections after pancreatic surgery. JAMA Surg 152:1023–1029
doi: 10.1001/jamasurg.2017.2155 pubmed: 28700780 pmcid: 5710411
Sugiura T, Uesaka K, Ohmagari N et al (2012) Risk factor of surgical site infection after pancreaticoduodenectomy. World J Surg 36:2888–2894
doi: 10.1007/s00268-012-1742-6 pubmed: 22907393
Suragul W, Rungsakulkij N, Vassanasiri W et al (2020) Predictors of surgical site infection after pancreaticoduodenectomy. BMC Gastroenterol 20:201–210
doi: 10.1186/s12876-020-01350-8 pubmed: 32586351 pmcid: 7318744
Donald GW, Sunjaya D, Lu X et al (2013) Perioperative antibiotics for surgical site infection in pancreaticoduodenectomy: does the SCIP-approved regimen provide adequate coverage? Surgery 154:190–196
doi: 10.1016/j.surg.2013.04.001 pubmed: 23664266
Mentor K, Ratnayake B, Akter N et al (2020) Meta-analysis and meta-regression of risk factors for surgical site infections in hepatic and pancreatic resection. World J Surg 44:4221–4230
doi: 10.1007/s00268-020-05741-6 pubmed: 32812136
Sugawara G, Ebata T, Yokoyama Y et al (2013) The effect of preoperative biliary drainage on infectious complications after hepatobiliary resection with cholangiojejunostomy. Surgery 153:200–210
doi: 10.1016/j.surg.2012.07.032 pubmed: 23044266
Berrios-Torres SI, Umscheid CA, Bratzler DW et al (2017) Centers for disease control and prevention guideline for the prevention of surgical site infection. JAMA Surg 152:784–791
doi: 10.1001/jamasurg.2017.0904 pubmed: 28467526
Jethwa P, Breuning E, Bhati C et al (2007) The microbiological impact of pre-operative biliary drainage on patients undergoing hepato-biliary-pancreatic (HPB) surgery. Aliment Pharmacol Ther 25:1175–1180
doi: 10.1111/j.1365-2036.2007.03289.x pubmed: 17451563
Bratzler DW, Dellinger EP et al (2013) Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 70:195–283
doi: 10.2146/ajhp120568 pubmed: 23327981
Itoyama R, Okabe H, Yamashita Y et al (2021) Intraoperative bile culture helps choosing antibiotics in pancreaticoduodenectomy: Mechanistic profiling study of complex rink between bacterobilia and postoperative complications. J Hepatobiliary Pancreat Sci 00:1–8
Sano S, Sugiura T, Kawamura I et al (2019) Third-generation cephalosporin for antimicrobial prophylaxis in pancreatoduodenectomy in patients with internal preoperative biliary drainage. Surgery 165:559–564
doi: 10.1016/j.surg.2018.09.011 pubmed: 30803620
Yamamoto Y, Ashida R, Ohgi K et al (2018) Combined antrectomy reduces the incidence of delayed gastric emptying after pancreatoduodenectomy. Dig Surg 35:121–130
doi: 10.1159/000474957 pubmed: 28467983
Kakita A, Yoshida M, Takahashi T (2001) History of pancreaticojejunostomy in pancreaticoduodenectomy: development of a more reliable anastomosis technique. J Hepatobiliary Pancreat Surg 8:230–237
doi: 10.1007/s005340170022 pubmed: 11455485
Hirono S, Kawai M, Okada K et al (2019) Modified Blumgart mattress suture versus conventional interrupted suture in pancreaticojejunostomy during pancreaticoduodenectomy: randomized controlled trial. Ann Surg 269:243–251
doi: 10.1097/SLA.0000000000002802 pubmed: 29697455
Advisory Committee of Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery Japanese Clinical Practice Guidelines for antimicrobial prophylaxis in surgery [in Japanese] (2016) J Jpn Soc Surg Infect 13:79–158
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 15273542 pmcid: 1360123
Mangram AJ, Horan TC, Pearson ML et al (1999) Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) hospital infection control practices advisory committee. Am J Infect Control 27(2):97–132
doi: 10.1016/S0196-6553(99)70088-X pubmed: 10196487
Bassi C, Marchegiani G, Dervenis C et al (2017) The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 161:584–591
doi: 10.1016/j.surg.2016.11.014 pubmed: 28040257
Koch M, Garden OJ, Padbury R et al (2011) Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 149:680–688
doi: 10.1016/j.surg.2010.12.002 pubmed: 21316725
Hata T, Mizuma M, Motoi F et al (2020) Early postoperative drainage fluid culture positivity from contaminated bile juice is predictive of pancreatic fistula after pancreaticoduodenectomy. Surg Today 50:248–257
doi: 10.1007/s00595-019-01885-8 pubmed: 31583471
Sugiura T, Mizuno T, Okamura Y et al (2015) Impact of bacterial contamination of the abdominal cavity during pancreaticoduodenectomy on surgical-site infection. Br J Surg 102:1561–1566
doi: 10.1002/bjs.9899 pubmed: 26206386
Owens CD, Stoessel K (2008) Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect 70(Suppl 2):3–10
doi: 10.1016/S0195-6701(08)60017-1 pubmed: 19022115
Callery MP, Pratt WB, Kent TS et al (2013) A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg 216:1–14
doi: 10.1016/j.jamcollsurg.2012.09.002 pubmed: 23122535
Kawaida H, Kono H, Hosomura N et al (2019) Surgical techniques and postoperative management to prevent postoperative pancreatic fistula after pancreatic surgery. World J Gastroenterol 25:3722–3737
doi: 10.3748/wjg.v25.i28.3722 pubmed: 31391768 pmcid: 6676555
Mathur A, Pitt HA, Marine M et al (2007) Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg 246:1058–1064
doi: 10.1097/SLA.0b013e31814a6906 pubmed: 18043111
Krawczyk B, Wityk P, Gałęcka M (2021) The many faces of Enterococcus spp.—commensal probiotic and opportunistic pathogen. Microorganisms 9:1900
doi: 10.3390/microorganisms9091900 pubmed: 34576796 pmcid: 8470767
Dervisoglou A, Tsiodras S, Kanellakopoulou K et al (2006) The value of chemoprophylaxis against Enterococcus species in elective cholecystectomy: a randomized study of cefuroxime versus ampicillin-sulbactam. Arch Surg 141:1162–1167
doi: 10.1001/archsurg.141.12.1162 pubmed: 17178957
Stack CM, Gold HS, Wright SB et al (2018) Perioperative antimicrobial prophylaxis and prevention of hepatobiliary surgical site infections. Infect Control Hosp Epidemiol 39:1037–1041
doi: 10.1017/ice.2018.164 pubmed: 30064539
Solomkin JS, Mazuski JE, Bradley JS et al (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50:133–164
doi: 10.1086/649554 pubmed: 20034345
Teshome BF, Vouri SM, Hampton N et al (2019) Duration of exposure to antipseudomonal β-lactam antibiotics in the critically ill and development of new resistance. Pharmacotherapy 39:261–270
doi: 10.1002/phar.2201 pubmed: 30506852 pmcid: 6507412

Auteurs

Taihei Soma (T)

Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Sunto-Nagaizumi, Shizuoka, 4118777, Japan.

Katsuhisa Ohgi (K)

Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Sunto-Nagaizumi, Shizuoka, 4118777, Japan. ka.ogi@scchr.jp.

Hanako Kurai (H)

Division of Infectious Disease, Shizuoka Cancer Center, Shizuoka, Japan.

Teiichi Sugiura (T)

Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Sunto-Nagaizumi, Shizuoka, 4118777, Japan.

Ryo Ashida (R)

Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Sunto-Nagaizumi, Shizuoka, 4118777, Japan.

Mihoko Yamada (M)

Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Sunto-Nagaizumi, Shizuoka, 4118777, Japan.

Shimpei Otsuka (S)

Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Sunto-Nagaizumi, Shizuoka, 4118777, Japan.

Akifumi Notsu (A)

Clinical Research Center, Shizuoka Cancer Center, Shizuoka, Japan.

Katsuhiko Uesaka (K)

Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Sunto-Nagaizumi, Shizuoka, 4118777, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH